This article was previously published in the ABA Section of Litigation Health Law Litigation newsletter
While the Department of Justice (DOJ) has long considered individual accountability a best practice, the release of the Yates Memo signals a major shift in policy that life sciences companies cannot afford to ignore.
The Yates Memo describes six key principles, which have been incorporated into the U.S. Attorneys Manual, to be considered by DOJ attorneys when investigating corporations for civil and criminal wrongdoing.
Navigant’s life sciences and legal industry experts breakdown what the Yates Memo means to the industry and the heightened pressures and critical decision points that need to be considered.